Peninsula Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$506K Buy
656
+50
+8% +$41.4K 0.09% 70
2024
Q3
$556K Buy
606
+21
+4% +$18.9K 0.1% 69
2024
Q2
$554K Buy
585
+11
+2% +$8.8K 0.1% 63
2024
Q1
$447K Buy
574
+4
+0.7% +$2.85K 0.09% 67
2023
Q4
$332K Buy
570
+86
+18% +$50.2K 0.07% 69
2023
Q3
$279K Buy
+484
New +$249K 0.07% 70

Other funds holding LLY

Peninsula Wealth's LLY Position: Q4 2024 in Review

Peninsula Wealth increased its Eli Lilly (LLY) stake by 8.3% in Q4 2024, buying an estimated $41.4K and bringing the position to 656 shares worth $506K. The position accounts for 0.09% of the portfolio, ranked #70.

Peninsula Wealth first reported a position in LLY in Q3 2023 and has held it in 6 quarters since. The position peaked at $556K in Q3 2024. 3,906 funds tracked by Wall St. Rank hold LLY as of Q4 2024.

  • Peninsula Wealth held 656 shares of Eli Lilly worth $506K as of Q4 2024.
  • Peninsula Wealth bought 50 Eli Lilly shares in Q4 2024, an estimated $41.4K.
  • Eli Lilly made up 0.09% of Peninsula Wealth's portfolio in Q4 2024, its #70 holding.
  • Peninsula Wealth first reported a position in Eli Lilly in Q3 2023 and has held it in 6 quarters since.
  • Peninsula Wealth's Eli Lilly position peaked at $556K in Q3 2024.
  • 3,906 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2024.

Based on Peninsula Wealth's 13F filing for Q4 2024, filed 13 Feb 2025.